XML 68 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Acquisitions and Other Transactions (Narrative) (Details)
€ in Millions
3 Months Ended 9 Months Ended
Jun. 22, 2020
USD ($)
Jun. 16, 2020
USD ($)
Jul. 29, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2020
EUR (€)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Jun. 25, 2021
EUR (€)
Jun. 22, 2020
EUR (€)
Dec. 31, 2019
USD ($)
Business Acquisition [Line Items]                    
Line of Credit Facility, Maximum Borrowing Capacity   $ 1,500,000,000                
Payments of Financing Costs           $ 1,800,000 $ 2,700,000      
Delayed draw term loan credit agreement   600,000,000.0                
Contingent consideration       $ 213,200,000   213,200,000       $ 250,700,000
Upjohn Inc.                    
Business Acquisition [Line Items]                    
Business Acquisition, Percentage of Voting Interests Acquired     43.00%              
Transaction costs       $ 30,000,000.0   $ 115,000,000.0        
Extension term of supply contract 4 years                  
Additional extension term of supply contract 1 year                  
Aspen Global Incorporated [Member]                    
Business Acquisition [Line Items]                    
Amount to acquire business | €         € 641.9          
Payments to acquire business | €         € 263.2          
Aspen Global Incorporated [Member] | Scenario, Plan [Member]                    
Business Acquisition [Line Items]                    
Contingent consideration | €               € 378.7    
Upjohn Inc.                    
Business Acquisition [Line Items]                    
Line of Credit Facility, Maximum Borrowing Capacity   $ 4,000,000,000.0                
Upjohn Inc. | United States of America, Dollars                    
Business Acquisition [Line Items]                    
Senior Notes $ 7,450,000,000                  
Upjohn Inc. | Euro Member Countries, Euro                    
Business Acquisition [Line Items]                    
Senior Notes | €                 € 3,600.0  
Upjohn Inc. | Pfizer, Inc.                    
Business Acquisition [Line Items]                    
Payments for Business Separation     $ 12,000,000,000.0              
Delayed draw term   18 months                
Product | Upjohn Inc.                    
Business Acquisition [Line Items]                    
Number Of Products     20              
Upjohn Inc. | Pfizer, Inc.                    
Business Acquisition [Line Items]                    
Noncontrolling Interest, Ownership Percentage by Parent     57.00%